Search results for: inverse floaters

Are there cracks in the credit market?

Record new debt issuance, lack of revenue growth, increased acquisition activity, and the re-emergence of debt-financed shareholder returns have caused deterioration in credit metrics. Corporations may not be as close to the end of their credit cycle as the deterioration in credit metrics would imply.

Tagged with: Fixed Income, Investing

Momentum investing — Understanding the risks

Momentum as a factor in investing decisions can be a valuable tool, but must be monitored carefully. Drawdowns can be severe if exposures are not structured mindfully.

Tagged with: Investing

Biosimilars — The next biopharmaceutical growth story

Biosimilars — copies of high-priced bio-engineered therapeutic proteins and antibodies — have begun to be approved by regulators in both the EU and U.S.
There are huge health and financial benefits to be derived from the development of biosimilar markets in mature therapeutic categories. Even greater opportunities exist in the discovery and development of innovative biologic drugs that will save and improve lives and reduce the burden of disease.

Tagged with: Industry/Sector Commentary, Investing

About Us

Columbia Threadneedle Investments is a leading global asset management group that provides a broad range of actively managed investment strategies and solutions for individual, institutional and corporate clients around the world. With more than 2,000 people, including over 450 investment professionals based in North America, Europe and Asia, we manage $503 billion†† of assets across developed and emerging market equities, fixed income, asset allocation solutions and alternatives.

††In U.S. dollars as of June 30, 2015. Source: Ameriprise Q2 Earnings Release. Includes all assets managed by entities in the Columbia and Threadneedle groups of companies. Contact us for more current data.